3859 results for «2262»
3859 results
TAVI: Full one-year Evolut low-risk randomised results and economic implications
EVOLUT Low Risk Trial of self-expanding TAVI versus SAVR: discover the key take-aways from the economic analysis as well as the health economics implications to understand the potential drivers for TAVI cost-effectives in Europe.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
Abstracts on Stable CAD - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of abstracts from PCR e-Course 2020 on the topic of Stable CAD:
- Safety and effectiveness of lithotripsy in calcified eccentric coronary lesions
- Constant resistance ratio of a pressure microcatheter validated using iFR
- Virtual stenting algorithm from FFR pullback: a proof of concept study
TAVI for bicuspid valves with Evolut: BIVOLUT-X registry
Learn more about transcatheter treatment of bicuspid aortic valves with the EVOLUT platform, the BIVOLUT-X registry design, and key outcomes and practical implications of the study.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
Procedural techniques for TAVI - Session with LIVE case
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to understand what are the crucial steps of TF TAVI that have been improved to optimise outcomes.
This session was originally presented during PCR e-Course 2020.
PICSO improves coronary microvascular function in patients with STEMI
25 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to learn about the latest OxAMI-PiCSO study clinical results and to learn about the first-in-man of PiCSO in inferior STEMI patients.
Videos included on this page: the Hot Line presentation, an Investigator Perspective and a Wrap Up discussion.
Prevention and management of coronary complications
25 Jun 2020 – From PCR e-Course 2020
Watch this session to discover clinical cases with different PCI-related complications, and learn how to minimise their risks and how to best manage them.
This session was originally presented during PCR e-Course 2020.
Low risk TAVI trials in the real world: where are we in 2020?
26 Jun 2020 – From PCR e-Course 2020
Watch this case discussion if you want to fully appreciate the impact of the low risk TAVI trials, to understand how to apply this information in your daily clinical practice and to translate clinical trial outcomes into real-world decisions by your Heart Team.
This session was originally...
TAVI and the conduction system
27 Jun 2020 – From PCR e-Course 2020
Watch this case discussion if you want to appreciate the factors that predict conduction abnormalities during TAVI (and how to avoid them), to understand which patients are at risk of late abnormalities and need prolonged monitoring after TAVI and to identify which patients require permanent pacemaker...
Hotlines and innovations on stable CAD - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of stable CAD:
- ANGIE trial
- Prevention of AKI with sodium bicarbonate
- AI-based plaque characterisation
Hotlines and innovations on bifurcation lesions - PCR e-Course 2020
View this hot line from PCR e-Course 2020 on the topic of bifurcation stenting regarding the role of deployment technique in a global registry.
Hotlines and innovations on other coronary interventions - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of other coronary interventions:
- Gender differences in outcomes after rational atherectomy PCI
- Intensified antiplatelet therapy in post-PCI patients with HOPR
Hotlines and innovations on valve interventions - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of valve interventions:
- Safety and efficacy of the TaurusOne TAVR system for aortic stenosis
- Quantitative angiographic assessment of MR after mitral procedures
Hotlines and innovations on STEMI - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of STEMI:
- Stenosis Severity and Complete Revascularisation in STEMI
- Analysis of changes in decision-making process during OCT-guided PCI
PCR e-Course 2020 Late-Breaking Trials – part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- Crossover results from the RADIANCE-HTN SOLO trial
- DynamX Bioadaptor, a novel « uncaging » platform
- Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
PCR e-Course 2020 Hot lines: TAVI – part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: PORTICO IDE, FlexNav Delivery System, FRANCE TAVI, BIVOLUT-X, VIVALL.
Revascularisation strategies - PCR e-Course 2020 Hot lines
29 Jul 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
CT guidance for coronary interventions - PCR e-Course 2020 Hot lines
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy
